Form 8-K - Current report:
SEC Accession No. 0001411685-24-000059
Filing Date
2024-12-06
Accepted
2024-12-06 16:49:35
Documents
72
Period of Report
2024-12-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtgn-20241206.htm   iXBRL 8-K 25158
2 EX-99.1 vistagencorporatepresent.htm EX-99.1 57862
6 vistagencorporatepresent001.jpg GRAPHIC 70688
7 vistagencorporatepresent002.jpg GRAPHIC 265380
8 vistagencorporatepresent003.jpg GRAPHIC 98952
9 vistagencorporatepresent004.jpg GRAPHIC 93224
10 vistagencorporatepresent005.jpg GRAPHIC 60651
11 vistagencorporatepresent006.jpg GRAPHIC 69463
12 vistagencorporatepresent007.jpg GRAPHIC 125267
13 vistagencorporatepresent008.jpg GRAPHIC 72001
14 vistagencorporatepresent009.jpg GRAPHIC 92002
15 vistagencorporatepresent010.jpg GRAPHIC 100348
16 vistagencorporatepresent011.jpg GRAPHIC 61383
17 vistagencorporatepresent012.jpg GRAPHIC 135053
18 vistagencorporatepresent013.jpg GRAPHIC 102641
19 vistagencorporatepresent014.jpg GRAPHIC 84465
20 vistagencorporatepresent015.jpg GRAPHIC 135132
21 vistagencorporatepresent016.jpg GRAPHIC 128347
22 vistagencorporatepresent017.jpg GRAPHIC 89112
23 vistagencorporatepresent018.jpg GRAPHIC 64785
24 vistagencorporatepresent019.jpg GRAPHIC 93114
25 vistagencorporatepresent020.jpg GRAPHIC 94451
26 vistagencorporatepresent021.jpg GRAPHIC 89546
27 vistagencorporatepresent022.jpg GRAPHIC 114094
28 vistagencorporatepresent023.jpg GRAPHIC 135920
29 vistagencorporatepresent024.jpg GRAPHIC 103052
30 vistagencorporatepresent025.jpg GRAPHIC 120033
31 vistagencorporatepresent026.jpg GRAPHIC 62706
32 vistagencorporatepresent027.jpg GRAPHIC 114150
33 vistagencorporatepresent028.jpg GRAPHIC 85662
34 vistagencorporatepresent029.jpg GRAPHIC 133073
35 vistagencorporatepresent030.jpg GRAPHIC 112744
36 vistagencorporatepresent031.jpg GRAPHIC 85887
37 vistagencorporatepresent032.jpg GRAPHIC 89553
38 vistagencorporatepresent033.jpg GRAPHIC 68235
39 vistagencorporatepresent034.jpg GRAPHIC 109706
40 vistagencorporatepresent035.jpg GRAPHIC 110148
41 vistagencorporatepresent036.jpg GRAPHIC 91966
42 vistagencorporatepresent037.jpg GRAPHIC 134667
43 vistagencorporatepresent038.jpg GRAPHIC 141402
44 vistagencorporatepresent039.jpg GRAPHIC 108247
45 vistagencorporatepresent040.jpg GRAPHIC 124370
46 vistagencorporatepresent041.jpg GRAPHIC 71556
47 vistagencorporatepresent042.jpg GRAPHIC 94931
48 vistagencorporatepresent043.jpg GRAPHIC 67558
49 vistagencorporatepresent044.jpg GRAPHIC 144760
50 vistagencorporatepresent045.jpg GRAPHIC 75889
51 vistagencorporatepresent046.jpg GRAPHIC 72602
52 vistagencorporatepresent047.jpg GRAPHIC 100180
53 vistagencorporatepresent048.jpg GRAPHIC 133211
54 vistagencorporatepresent049.jpg GRAPHIC 159524
55 vistagencorporatepresent050.jpg GRAPHIC 67564
56 vistagencorporatepresent051.jpg GRAPHIC 91806
57 vistagencorporatepresent052.jpg GRAPHIC 136675
58 vistagencorporatepresent053.jpg GRAPHIC 66355
59 vistagencorporatepresent054.jpg GRAPHIC 95298
60 vistagencorporatepresent055.jpg GRAPHIC 110379
61 vistagencorporatepresent056.jpg GRAPHIC 54879
62 vistagencorporatepresent057.jpg GRAPHIC 131294
63 vistagencorporatepresent058.jpg GRAPHIC 62808
  Complete submission text file 0001411685-24-000059.txt   8371025

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtgn-20241206.xsd EX-101.SCH 1785
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtgn-20241206_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtgn-20241206_pre.xml EX-101.PRE 12510
74 EXTRACTED XBRL INSTANCE DOCUMENT vtgn-20241206_htm.xml XML 2729
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 241532957
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)